Research graph
References from Win Ratios in Ophthalmology—a Hierarchical Metric to Evaluate Adverse Outcomes in Comparative Studies. Local targets link to admitted publications; unresolved targets remain external evidence.
Treatment outcomes in the primary tube versus trabeculectomy study after 5 years of follow-up
10.1016/j.ophtha.2022.07.003 · 2022 · External reference
Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (tags)
2021 · External reference
Laser in glaucoma and ocular hypertension (light) trial: six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension
10.1016/j.ophtha.2022.09.009 · 2023 · External reference
Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial
10.1016/s0140-6736(18)32607-2 · 2019 · External reference
Rethinking prophylactic laser peripheral iridotomy in primary angle-closure suspects: a review
10.1016/j.ogla.2023.06.004 · 2023 · External reference
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
10.1093/eurheartj/ehr352 · 2012 · External reference
Hierarchical composite outcomes and win ratio methods in cardiovascular trials: a review and consequent guidance
10.1161/circulationaha.124.070251 · 2025 · External reference
Efficient capture of high-quality real-world data on treatments for glaucoma: the Fight Glaucoma Blindness! registry
10.1136/bmjophth-2021-000903 · 2021 · External reference
Visual rehabilitation in subconjunctival MIGS versus trabeculectomy and tube shunt surgery
10.1016/j.ajoint.2025.100108 · 2025 · External reference
Association between prior selective laser trabeculoplasty and phaco-istent inject efficacy
10.1111/ceo.14588 · 2025 · External reference
Long-term comparative outcomes of Hydrus versus Istent Inject microinvasive glaucoma surgery implants combined with cataract surgery
10.1136/bjo-2025-327359 · 2025 · External reference
The win ratio in cardiology trials: lessons learnt, new developments, and wise future use
10.1093/eurheartj/ehae647 · 2024 · External reference
Outcomes and baseline predictors of failure in primary standalone Xen45 gel stent vs trabeculectomy for glaucoma
10.1016/j.ogla.2024.07.002 · 2024 · External reference
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
10.1056/nejmoa062655 · 2006 · External reference
The advanced glaucoma intervention study (agis): 4. Comparison of treatment outcomes within race. Seven-year results
10.1016/s0161-6420(98)97013-0 · 1998 · External reference
Impact of different intraocular pressure and medication endpoint criteria on success rates in subconjunctival minimally invasive glaucoma surgery
10.1097/ijg.0000000000002639 · 2025 · External reference
Risk factors for failure in minimally invasive bleb surgery: a systematic review
10.1016/j.ajo.2025.11.045 · 2025 · External reference
Meaningful patient partnerships: a qualitative study of patient perspectives and shared decision-making regarding glaucoma surgery
10.1016/j.ogla.2025.04.006 · 2025 · External reference
Clinical registries in ophthalmology
10.1016/j.ophtha.2018.12.030 · 2019 · External reference
Comparing outcomes of 45 μm gelatin stent placed ab externo with open conjunctiva to ab externo with closed conjunctiva
10.1016/j.ogla.2023.07.009 · 2024 · External reference
Interim analysis of clinical outcomes with open versus closed conjunctival implantation of the Xen45 gel stent
10.1016/j.ogla.2023.09.001 · 2024 · External reference
Trabeculectomy augmented with anti-vegf improves surgical outcomes in glaucoma: a systematic review and meta-analysis
10.1016/j.ajo.2025.05.005 · 2025 · External reference
